Iterum Therapeutics Plc (ITRM) Tops Q1 EPS by 5c

Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q1 EPS of ($0.10), $0.05 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.

You May Also Be Interested In

• Seaport Global Securities Downgrades JetBlue Airways (JBLU) to Neutral
• Bitmine reports 5.82 million ETH holdings, $11.4B total assets
• L3Harris CEO steps down amid conduct review, shares drop